Community-acquired pneumonia in adults: Guidelines for management

Clinical Infectious Diseases

Volumn 26, Issue 4, 1998, Pages 811-838

  Bartlett, John G ^a   Breiman, Robert F ^b   Mandell, Lionel A ^b   File Jr , Thomas M ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; INFLUENZA VACCINE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; RIFAMPICIN;

ANAEROBIC BACTERIUM; ASPIRATION PNEUMONIA; BACTERIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; COMMUNICABLE DISEASE; DIAGNOSTIC PROCEDURE; EMPYEMA; HANTAVIRUS PULMONARY SYNDROME; HOSPITALIZATION; HUMAN; INFLUENZA; INTRAVENOUS DRUG ADMINISTRATION; LEGIONELLA; LEGIONNAIRE DISEASE; MYCOPLASMA PNEUMONIA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA; SURGICAL DRAINAGE;

EID: 0031894382     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513953     Document Type: Review

References (16)

1. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial empiric therapy of community-acquired pneumonia: proceedings of an American Thoracic Society Consensus Conference. Am Rev Resp Dis 1993;148:1418-26.
2. The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993;49:346-50.
3. Mandell LA, Niederman M. The Canadian Community-Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can J Infect Dis 1993;4:25.
4. Gross PA, Barrett TL, Dellinger P, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis 1994;18:421.
5. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996;275:189-93.
6. Centers for Disease Control and Prevention. Premature deaths, monthly mortality and monthly physician contacts - United States. MMWR Morb Mortal Wkly Rep 1997;46:556.
7. Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalizations: results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157:1509-718.
8. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996;275:134-41.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
10. Heffron R. The pneumococcus. Boston: Harvard University Press, 1938.
11. Gilbert K, Fine MJ. Assessing prognosis and predicting patient outcomes in community-acquired pneumonia. Semin Respir Infect 1994;9: 140-52.
12. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994;96:313-20.
13. Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997;157:1446-52.
14. Fine MJ, Orloff JJ, Arisumi D, et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med 1990;88:1N-8N.
15. Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 1990;89:713-21.
16. Poe RH, Wahl GW, Qazi R, et al. Predictors of mortality in the immuno-compromised patient with pulmonary infiltrates. Arch Intern Med 1986;146:1304-8.